ClinicalTrials.gg
CompletedNCT07378748BM-BOMUpdated Jan 30, 2026

Effect of Bedtime Mindfulness Meditation on Anxiety and Spiritual Well-Being in Hemodialysis Patients

An interventional study of Bedtime Meditation Based on Mindfulness (BM-BOM) and Passive Rest (Control) in Chronic Kidney Disease, Hemodialysis and Anxiety, sponsored by Universitas Muhammadiyah Surakarta. Completed at 1 site in Indonesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-30.

Sponsored by Universitas Muhammadiyah Surakarta · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jun 2025, registered Jan 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 23 studies in Renal Insufficiency, Chronic with a site in Indonesia — 6 open to participants now, 6 under way, 1 of them phase 3. Renal Insufficiency, Chronic · Indonesia.

Enrollment
7th of 16
58 · median 45
Started
2025
with 2 others
No phase
9 of 23
3 open now
Registered
17th of 23
by date
Lead sponsor
2 of 23
Universitas Muhammadiyah Surakarta

Among the 23 studies in Renal Insufficiency, Chronic with a site in Indonesia, this one is the 7th largest by enrollment of the 16 interventional ones that give a count, is one of 3 that started in 2025, is one of 9 with no phase, and was the 17th registered.

Renal Insufficiency, Chronic

3,098 studies on the registry are indexed under Renal Insufficiency, Chronic; 700 are open to participants now.

Browse Renal Insufficiency, Chronic studies →

Open to participants now

6 of the 23 studies in Renal Insufficiency, Chronic with a site in Indonesia are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →

Who these studies take

Of the 434 Renal Insufficiency, Chronic studies recruiting now, 245 (56%) set no upper age limit and 110 (25%) stop at 75 or younger; 43 take children under 18; 80 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Renal Insufficiency, Chronic with a site in Indonesia, or all of them as a file.
02

Study summary

This study evaluates whether Bedtime Meditation Based on Mindfulness (BM-BOM) can reduce anxiety and improve spiritual well-being in patients undergoing hemodialysis.

People receiving long-term hemodialysis often experience emotional stress, anxiety, and spiritual distress due to chronic illness, treatment burden, and lifestyle limitations. These problems may affect their quality of life and overall well-being. Mindfulness meditation is a simple, low-cost, and safe non-drug approach that may help patients feel calmer, more focused, and more spiritually connected.

In this study, adult hemodialysis patients are randomly assigned to one of two groups. The intervention group receives a guided mindfulness meditation program. Participants attend a single 2.5-hour training session led by a certified mindfulness instructor and then practice guided meditation during their hemodialysis sessions twice a week for four weeks using audio recordings. Each session lasts approximately 15 minutes and includes breathing awareness, body awareness, and short reflection.

The control group follows the same schedule and duration but rests quietly with eyes closed without guided meditation.

Participants complete questionnaires before and after the four-week program to measure anxiety and spiritual well-being. The results of this study will help determine whether guided mindfulness meditation can be used as a practical and supportive complementary therapy for patients receiving hemodialysis.

Read the detailed description

This randomized controlled trial investigates the effectiveness of Bedtime Meditation Based on Mindfulness (BM-BOM) in reducing anxiety and improving spiritual well-being among patients undergoing maintenance hemodialysis.

Hemodialysis patients frequently experience psychological distress, including anxiety, emotional burden, and spiritual challenges associated with long-term treatment dependency, physical limitations, and uncertainty about health outcomes. Although standard hemodialysis care focuses primarily on physiological management, psychosocial and spiritual needs are often insufficiently addressed. Mindfulness-based interventions offer a structured, non-pharmacological approach that promotes present-moment awareness, emotional regulation, relaxation, and adaptive coping. However, evidence regarding their combined effects on anxiety and spiritual well-being in hemodialysis populations remains limited.

This study employs a single-blind randomized controlled design with pre- and post-intervention measurements. Eligible participants are adult patients with stage V chronic kidney disease who have been receiving outpatient hemodialysis for at least three months and are able to communicate effectively and provide informed consent. Participants with severe cognitive impairment, diagnosed psychological disorders, or medical conditions that prevent participation in the intervention are excluded.

A total of 58 participants are randomly allocated in a 1:1 ratio to either the intervention group or the control group using a computer-generated randomization sequence. Participants are blinded to group allocation. Outcomes are assessed using self-reported standardized questionnaires administered at baseline and again after completion of the four-week intervention period.

Participants in the intervention group receive a structured mindfulness program. The program begins with a single 2.5-hour face-to-face training session delivered by a certified mindfulness practitioner, introducing core principles of mindfulness, breathing awareness, and body awareness. Following the training, participants practice guided BM-BOM at the beginning of each hemodialysis session, twice weekly for four consecutive weeks. Each session lasts approximately 15 minutes and is delivered using standardized audio guidance in the Indonesian language. The audio guidance includes three sequential components: focused breathing awareness (approximately 5 minutes), body scan and bodily awareness (approximately 7 minutes), and closing reflection and grounding (approximately 3 minutes). Attendance and adherence are monitored during each session.

Participants in the control group follow the same schedule, setting, and duration but do not receive mindfulness guidance. They are instructed to rest quietly with eyes closed during the first 15 minutes of hemodialysis. This approach controls for time, attention, and environmental exposure while minimizing expectancy effects.

The primary outcomes are changes in spiritual well-being and anxiety levels from baseline to post-intervention. Spiritual well-being is measured using the Indonesian version of the Spiritual Well-Being Scale (SWBS), and anxiety is assessed using the Indonesian version of the Zung Self-Rating Anxiety Scale (ZSARS). Both instruments have demonstrated acceptable validity and reliability in Indonesian populations.

Data analysis includes descriptive statistics to summarize participant characteristics and inferential testing to compare within-group and between-group changes. Normality and homogeneity assumptions are evaluated prior to hypothesis testing. Paired statistical tests are used to assess pre- and post-intervention changes within groups, and independent statistical tests are used to compare outcome differences between groups. Effect sizes are calculated to support interpretation of clinical relevance.

Ethical approval is obtained from the institutional research ethics committee, and all participants provide written informed consent prior to participation. Participant confidentiality is maintained throughout the study in accordance with ethical guidelines.

The findings of this trial aim to provide evidence on the feasibility, safety, and effectiveness of guided mindfulness meditation as a complementary intervention that can be integrated into routine hemodialysis care to support psychological and spiritual well-being.

03

Conditions studied

  • Chronic Kidney Disease
  • Hemodialysis
  • Anxiety
  • Spiritual Well-being

Keywords

  • Bedtime Meditation
  • Spiritual Well-Being
  • Hemodialysis Patients
  • Anxiety Reduction
  • BM-BOM
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with chronic kidney disease (CKD) stage V.
  • Undergoing outpatient hemodialysis for at least three months.
  • Aged 18 years or older.
  • Able to communicate effectively.
  • Willing to participate and provide written .

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment.
  • Diagnosed psychological or psychiatric disorders.
  • Any medical condition that prevents participation in the mindfulness intervention.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
58 participants (actual)

Study arms

  • Experimental
    BM-BOM Intervention Group

    Participants received a 2.5-hour face-to-face mindfulness training delivered by a certified practitioner, followed by guided Bedtime Meditation Based on Mindfulness (BM-BOM) practice during hemodialysis sessions twice weekly for four consecutive weeks. Each session lasted approximately 15 minutes and was delivered using standardized audio guidance consisting of breathing awareness, body scan, and closing reflection.

    Behavioral: Bedtime Meditation Based on Mindfulness (BM-BOM)

  • Active comparator
    Control Group (Passive Rest)

    Participants rested quietly with their eyes closed for approximately 15 minutes at the beginning of each hemodialysis session twice weekly for four weeks, without structured mindfulness guidance. This controlled for time, attention, and treatment environment

    Behavioral: Passive Rest (Control)

Interventions

  • BehavioralBedtime Meditation Based on Mindfulness (BM-BOM)

    A structured mindfulness-based intervention consisting of guided breathing awareness, body scan, and closing reflection delivered via standardized audio recordings. Participants practiced BM-BOM for approximately 15 minutes during hemodialysis sessions twice per week for four weeks after completing a 2.5-hour introductory training session led by a certified mindfulness practitioner.

  • BehavioralPassive Rest (Control)

    Participants rested quietly with eyes closed for approximately 15 minutes during hemodialysis sessions without any guided mindfulness or structured intervention.

06

What researchers measure

Primary outcomes

  1. Change in Spiritual Well-Being Score

    Spiritual well-being will be measured using the Indonesian version of the Spiritual Well-Being Scale (SWBS). The SWBS assesses overall spiritual well-being through self-reported questionnaire items. Higher scores indicate better spiritual well-being. The primary outcome is the change in SWBS total score from baseline to post-intervention.

    Time frame: Baseline (Week 0) and after 4 weeks of intervention (Week 4)

Secondary outcomes

  1. Change in Anxiety Score

    Anxiety will be assessed using the Indonesian version of the Zung Self-Rating Anxiety Scale (ZSARS), a 20-item self-reported questionnaire. Higher scores indicate higher anxiety levels. The secondary outcome is the change in ZSARS total score from baseline to post-intervention.

    Time frame: Baseline (Week 0) and after 4 weeks of intervention (Week 4)

07

Study locations

1 site
  • UNS Hospital
    Surakarta, Centre Java 57126, Indonesia
08

References and documents

Publications

  • Murwani WG, Rosyid FN, Hudiyawati D. Effect of Bedtime Meditation on Spiritual Well-Being and Anxiety in Hemodialysis Patients: A Randomized Controlled Trial. Manuscript in preparation / submitted for publication, 2025.

Individual participant data

Plan to share: No — There is no plan to share individual participant data (IPD) with external researchers. The dataset will remain confidential and will only be accessible to the research team, in accordance with ethical approval and data protection regulations.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2025 to primary completion in Jul 2025, 1 month.

Of 580 non-industry interventional studies with no phase under Renal Insufficiency, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 45. This study's 1 month is below that.

Counting every sponsor, half of 620 studies reached it within 23 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2026
First posted
Jan 30, 2026
StartActual
Jun 1, 2025
Primary completionActual
Jul 30, 2025
CompletionActual
Jul 30, 2025
Last update
Jan 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07378748
Lead sponsor
Universitas Muhammadiyah Surakarta
Responsible party
Wara Gati Murwani (Ners., Universitas Muhammadiyah Surakarta) — Principal investigator
First posted
Jan 30, 2026
Start date
Jun 1, 2025
Primary completion
Jul 30, 2025
Completion
Jul 30, 2025
Last update
Jan 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion